Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.
about
Discovery and validation of new potential biomarkers for early detection of colon cancerDiagnostics and Epidemiology of Colorectal CancerColorectal endoscopic submucosal dissection from a Western perspective: Today's promises and future challengesColorectal cancer diagnosis: Pitfalls and opportunitiesColorectal cancer screening: the time to act is nowReducing inequities in colorectal cancer screening in North AmericaColorectal Cancer Biomarkers: Where Are We Now?The value of models in informing resource allocation in colorectal cancer screening: the case of The NetherlandsAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?The emerging role of GATA transcription factors in development and diseaseOccupational exposures and colorectal cancers: a quantitative overview of epidemiological evidenceMendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.Limited health literacy is a barrier to colorectal cancer screening in England: evidence from the English Longitudinal Study of AgeingTime lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark.State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences.Validity of data in the Danish Colorectal Cancer Screening Database.Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme.How different is cancer control across Canada? Comparing performance indicators for prevention, screening, diagnosis, and treatment.Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas.Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: results from a pragmatic cluster randomized controlled trial.Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacityIntestinal schistosomiasis in mothers and young children in Uganda: investigation of field-applicable markers of bowel morbidity.Colorectal cancer: from prevention to personalized medicine.Colorectal cancer population screening programs worldwide in 2016: An updateThe four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosisCMOST: an open-source framework for the microsimulation of colorectal cancer screening strategiesAssociation between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.Geographical variation and factors associated with colorectal cancer mortality in a universal health care system.Mortality results from the Göteborg randomised population-based prostate-cancer screening trialPredicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool.Developing screening services for colorectal cancer on Android smartphonesChild-Pugh score is an independent risk factor for immediate bleeding after colonoscopic polypectomy in liver cirrhosis.The effectiveness of a rapid-access flexible sigmoidoscopy clinic in a district hospitalTest characteristics of faecal immunochemical tests (FIT) compared with optical colonoscopy.Efficacy of an educational intervention on family physicians' risk assessment and management of colorectal cancer.Potential biases in colorectal cancer screening using faecal occult blood test.Colorectal cancer screening using flexible sigmoidoscopy: United Kingdom study demonstrates significant incidence and mortality benefit.Communicating the benefits and harms of colorectal cancer screening needed for an informed choice: a systematic evaluation of leaflets and bookletsEffect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screeningDoes access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: A pragmatic cluster randomized controlled trial study protocol.
P2860
Q21131953-C61246F2-3F1A-46D0-8D7E-7C6AB77F5099Q26738813-2AFD5D24-573D-4A65-BAC9-D22A6386DDF9Q26770017-0F519456-5318-472F-B7BB-C5D57AB4D062Q26774105-4D0EAA31-695F-4771-A682-5B91B7C9B7C6Q26784023-536295B5-DBC1-46D7-B454-5AEA79DAFB5FQ26859952-1BEFF0EA-DB57-41DB-BF5B-1A28B0FC21E4Q27003134-EE12BE04-6C02-43DF-AA4D-127B06873FB4Q27015647-88F323E6-C7A3-48F2-BDB5-D900A0673661Q27024427-5ED8D67B-7EDA-42C6-9CF1-03E03DCC5ADAQ28071681-80FB0A83-9C17-41DF-BBBF-4B85F5CFE58AQ28394573-42C6761F-C990-46C9-8C94-8B5B15746A04Q30252873-3AD364B6-2A10-4995-8C83-D23C45E08933Q30574873-E4A5A92B-452F-4096-AA7A-65CC67AB8F36Q30585169-39AAB07F-CA8D-4BB2-A78A-E0B6172C320BQ30666588-4AD9C07C-FDC3-4C51-A438-73CAE06226A0Q31169982-5A127C88-D96B-4FE2-AF4B-DE8A21699C05Q33403635-17946D97-1EC4-4BE7-A7ED-5AF46B6E1D04Q33611092-B37C099B-6EEB-4DC9-A62B-E19D9F75F080Q33618421-02E21A6D-1EA2-4374-9B50-73CE81F95069Q33622123-D02C47AA-4E69-49F5-BE65-01061E8B751CQ33695329-F917F0F8-22E4-42F3-BFF9-D1FECBF9F53BQ33734248-98A0390E-7617-4158-8A31-F30563C33B8CQ33735234-3818409C-50B0-4A41-BFBD-980449BD39F6Q33740455-EBFDE0D2-C41A-4123-9E6D-E6601A3B79A8Q33745941-745ADE46-F634-4642-9F5F-D67F6C16A142Q33768335-CA8EFF11-69BC-4326-BC27-AFBBB28BB961Q33807093-77F8304F-2505-4F73-8BD6-C9F0A5FF4B84Q33810166-8F045F0D-F6BD-4F9B-BA69-A3721746097CQ33873969-DC4E39A9-803A-45F3-9F52-096311E108DBQ33926473-4D549A1A-E94E-4755-8144-DF00493D0AEFQ33931445-70BEAD51-8F8D-4560-8688-788E86AAB798Q33941612-CF65D53D-4E5B-45C8-9C3F-1D8AE692C750Q33966311-774265A7-2A56-4240-9D0F-96E39E03940EQ34084455-20B225CE-55B9-4D36-BD1F-9833E034C85CQ34156897-B816036D-CDE6-4314-81D0-F79646B7DEFDQ34158426-AF88C84D-B7D3-4455-8EF3-145A315B6BD3Q34161146-B0BF769D-CD22-4243-86D4-A4FED6765423Q34172807-1A8338EE-E193-4556-A042-1C4A85F0B507Q34247210-A24BC1AA-5E1B-43D4-96D6-0AD6A8B397C6Q34274783-1D049A7B-C1FC-4DC0-B69C-B59EA4B4DEB0
P2860
Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Cochrane systematic review of ...... d test (hemoccult): an update.
@ast
Cochrane systematic review of ...... d test (hemoccult): an update.
@en
type
label
Cochrane systematic review of ...... d test (hemoccult): an update.
@ast
Cochrane systematic review of ...... d test (hemoccult): an update.
@en
prefLabel
Cochrane systematic review of ...... d test (hemoccult): an update.
@ast
Cochrane systematic review of ...... d test (hemoccult): an update.
@en
P2093
P2860
P1476
Cochrane systematic review of ...... d test (hemoccult): an update.
@en
P2093
Bernie Towler
Eila Watson
Paul Hewitson
P2860
P304
P356
10.1111/J.1572-0241.2008.01875.X
P407
P577
2008-05-13T00:00:00Z